Donation after Circulatory Death
Mar Lomero(Conseil de L'Europe), Beatriz Domínguez‐Gil(Universidad de Zaragoza), Marta López‐Fraga(University of Antwerp), Elisabeth Coll(Organización Nacional de Trasplantes), John H. Dark(Newcastle University), Stein Foss(Oslo University Hospital), Tamar Ashkenazi(Israel Ministry of Health), Luc Colenbie(Directorate-General for Health and Food Safety), Janis Jushinskis(Latvian Biomedical Research and Study Centre), Bernadette Haase- Kromwijk(Dutch Institute for Clinical Auditing), Corinne Antoine(Agence de la Biomédecine), Mark Jones(Belfast Health and Social Care Trust), Francesco Procaccio(Istituto Superiore di Sanità), Catarina Bolotinha(Instituto Portugues do Sangue e da Transplantacao, IP), Preysmil Fryda(European Council), Rachel Johnson(Emory University), Nichon Jansen, Sophie Hughes(University of Oxford), Nessa Lynch
Cited by 6
Related Papers
Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery
|Diabetes Care|2010|731
Kidney donation after circulatory death (DCD): state of the art
|Kidney International|2015|320
Donation after circulatory death today: an updated overview of the European landscape
|Transplant International|2019|317
COVID-19 pandemic and worldwide organ transplantation: a population-based study
|The Lancet Public Health|2021|312